First People's Hospital Of Hangzhou
Clinical trials sponsored by First People's Hospital Of Hangzhou, explained in plain language.
-
New hope for older AML patients: drug combo aims to control disease
Disease control Not yet recruitingThis study tests a combination of three drugs (venetoclax, homoharringtonine, and azacitidine) plus a growth factor (G-CSF) in 61 older or frail adults newly diagnosed with acute myeloid leukemia (AML) who cannot tolerate standard intensive chemotherapy. The goal is to see if thi…
Phase: PHASE2 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
New study tests easier antibiotic schedule for stomach bug
Disease control Not yet recruitingThis study tests two ways to take antibiotics for H. pylori, a stomach infection that can cause ulcers. All 240 participants will take tegoprazan twice a day for 14 days. One group will take amoxicillin three times a day, the other twice a day—both with the same total daily dose.…
Phase: PHASE4 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
New fibroid removal bag cuts surgery time in half, early data shows
Symptom relief Not yet recruitingThis study compares a new single-channel retrieval bag to a standard dual-channel bag for laparoscopic removal of uterine fibroids in 78 women aged 18-45 who want to keep their uterus. The new bag aims to shorten surgery time and make the procedure easier for surgeons. Early resu…
Phase: NA • Sponsor: First People's Hospital of Hangzhou • Aim: Symptom relief
Last updated Apr 29, 2026 15:05 UTC